{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T02:25:07Z","timestamp":1783736707324,"version":"3.55.0"},"reference-count":144,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM113242"],"award-info":[{"award-number":["R01 GM113242"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM122080"],"award-info":[{"award-number":["R01 GM122080"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012483","name":"University of Georgia Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Obstructive sleep apnea (OSA) results in systemic intermittent hypoxia. By one model, hypoxic stress signaling in OSA patients alters the levels of inflammatory soluble cytokines TNF and IL6, damages the blood brain barrier, and activates microglial targeting of neuronal cell death to increase the risk of neurodegenerative disorders and other diseases. However, it is not yet clear if OSA significantly alters the levels of the soluble isoforms of TNF receptors TNFR1 and TNFR2 and IL6 receptor (IL6R) and co-receptor gp130, which have the potential to modulate TNF and IL6 signaling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Picogram per milliliter levels of the soluble isoforms of these four cytokine receptors were estimated in OSA patients, in OSA patients receiving airways therapy, and in healthy control subjects. Triplicate samples were examined using Bio-Plex fluorescent bead microfluidic technology. The statistical significance of cytokine data was estimated using the nonparametric Wilcoxon rank-sum test. The clustering of these high-dimensional data was visualized using<jats:italic>t<\/jats:italic>-distributed stochastic neighbor embedding (t-SNE).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>OSA patients had significant twofold to sevenfold reductions in the soluble serum isoforms of all four cytokine receptors, gp130, IL6R, TNFR1, and TNFR2, as compared with control individuals (<jats:italic>p<\/jats:italic>\u2009=\u20091.8\u2009\u00d7\u200910<jats:sup>\u221213<\/jats:sup>to 4\u2009\u00d7\u200910<jats:sup>\u22128<\/jats:sup>). Relative to untreated OSA patients, airways therapy of OSA patients had significantly higher levels of gp130 (<jats:italic>p<\/jats:italic>\u2009=\u20092.8\u2009\u00d7\u200910<jats:sup>\u221213<\/jats:sup>), IL6R (<jats:italic>p<\/jats:italic>\u2009=\u20091.1\u2009\u00d7\u200910<jats:sup>\u22129<\/jats:sup>), TNFR1 (<jats:italic>p<\/jats:italic>\u2009=\u20092.5\u2009\u00d7\u200910<jats:sup>\u221210<\/jats:sup>), and TNFR2 (<jats:italic>p<\/jats:italic>\u2009=\u20095.7\u2009\u00d7\u200910<jats:sup>\u22129<\/jats:sup>), levels indistinguishable from controls (<jats:italic>p<\/jats:italic>\u2009=\u20090.29 to 0.95). The data for most airway-treated patients clustered with healthy controls, but the data for a few airway-treated patients clustered with apneic patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with OSA have aberrantly low levels of four soluble cytokine receptors associated with neurodegenerative disease, gp130, IL6R, TNFR1, and TNFR2. Most OSA patients receiving airways therapy have receptor levels indistinguishable from healthy controls, suggesting a chronic intermittent hypoxia may be one of the factors contributing to low receptor levels in untreated OSA patients.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s11325-020-02205-y","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T23:03:55Z","timestamp":1602284635000},"page":"1641-1653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy"],"prefix":"10.1007","volume":"25","author":[{"given":"Ye","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3928-8403","authenticated-orcid":false,"given":"Richard B.","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Ambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley G.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"issue":"2","key":"2205_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12640-013-9379-2","volume":"24","author":"MA Daulatzai","year":"2013","unstructured":"Daulatzai MA (2013) Death by a thousand cuts in Alzheimer\u2019s disease: hypoxia--the prodrome. Neurotox Res 24(2):216\u2013243","journal-title":"Neurotox Res"},{"issue":"6","key":"2205_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.mehy.2005.06.014","volume":"65","author":"B Abrams","year":"2005","unstructured":"Abrams B (2005) Add Alzheimer\u2019s to the list of sleep apnea consequences. Med Hypotheses 65(6):1201\u20131202","journal-title":"Med Hypotheses"},{"issue":"1","key":"2205_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000447560","volume":"17","author":"VN Quaranta","year":"2017","unstructured":"Quaranta VN, Carratu P, Damiani MF, Dragonieri S, Capozzolo A, Cassano A et al (2017) The prognostic role of obstructive sleep apnea at the onset of amyotrophic lateral sclerosis. Neurodegener Dis 17(1):14\u201321","journal-title":"Neurodegener Dis"},{"issue":"12","key":"2205_CR4","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.5664\/jcsm.5274","volume":"11","author":"JJ Sheu","year":"2015","unstructured":"Sheu JJ, Lee HC, Lin HC, Kao LT, Chung SD (2015) A 5-year follow-up study on the relationship between obstructive sleep apnea and Parkinson disease. J Clin Sleep Med 11(12):1403\u20131408","journal-title":"J Clin Sleep Med"},{"issue":"1","key":"2205_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.5665\/sleep.3332","volume":"37","author":"AB Neikrug","year":"2014","unstructured":"Neikrug AB, Liu L, Avanzino JA, Maglione JE, Natarajan L, Bradley L, Maugeri A, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S (2014) Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea. Sleep. 37(1):177\u2013185","journal-title":"Sleep."},{"key":"2205_CR6","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.msard.2018.12.015","volume":"28","author":"OA Abdel Salam","year":"2019","unstructured":"Abdel Salam OA, Ghonimi NAM, Ismail MH (2019) Risk of obstructive sleep apnea in multiple sclerosis: frequency, clinical and radiological correlates. Mult Scler Relat Disord 28:184\u2013188","journal-title":"Mult Scler Relat Disord"},{"issue":"4","key":"2205_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s11325-011-0642-6","volume":"16","author":"RA Dias","year":"2012","unstructured":"Dias RA, Hardin KA, Rose H, Agius MA, Apperson ML, Brass SD (2012) Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study. Sleep Breath 16(4):1255\u20131265","journal-title":"Sleep Breath"},{"key":"2205_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jad.2016.02.060","volume":"197","author":"B Stubbs","year":"2016","unstructured":"Stubbs B, Vancampfort D, Veronese N, Solmi M, Gaughran F, Manu P, Rosenbaum S, de Hert M, Fornaro M (2016) The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: a systematic review and meta-analysis. J Affect Disord 197:259\u2013267","journal-title":"J Affect Disord"},{"issue":"1","key":"2205_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.schres.2015.11.014","volume":"170","author":"H Myles","year":"2016","unstructured":"Myles H, Myles N, Antic NA, Adams R, Chandratilleke M, Liu D, Mercer J, Vakulin A, Vincent A, Wittert G, Galletly C (2016) Obstructive sleep apnea and schizophrenia: a systematic review to inform clinical practice. Schizophr Res 170(1):222\u2013225","journal-title":"Schizophr Res"},{"issue":"9","key":"2205_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.sleep.2011.08.003","volume":"12","author":"S Pamidi","year":"2011","unstructured":"Pamidi S, Knutson KL, Ghods F, Mokhlesi B (2011) Depressive symptoms and obesity as predictors of sleepiness and quality of life in patients with REM-related obstructive sleep apnea: cross-sectional analysis of a large clinical population. Sleep Med 12(9):827\u2013831","journal-title":"Sleep Med"},{"issue":"2","key":"2205_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.sleep.2005.06.005","volume":"7","author":"PJ Deldin","year":"2006","unstructured":"Deldin PJ, Phillips LK, Thomas RJ (2006) A preliminary study of sleep-disordered breathing in major depressive disorder. Sleep Med 7(2):131\u2013139","journal-title":"Sleep Med"},{"issue":"4","key":"2205_CR12","first-page":"696","volume":"125","author":"J Feng","year":"2012","unstructured":"Feng J, Wu Q, Zhang D, Chen BY (2012) Hippocampal impairments are associated with intermittent hypoxia of obstructive sleep apnea. Chin Med J 125(4):696\u2013701","journal-title":"Chin Med J"},{"issue":"1","key":"2205_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11325-008-0198-2","volume":"13","author":"A Haensel","year":"2009","unstructured":"Haensel A, Bardwell WA, Mills PJ, Loredo JS, Ancoli-Israel S, Morgan EE, Heaton RK, Dimsdale JE (2009) Relationship between inflammation and cognitive function in obstructive sleep apnea. Sleep Breath 13(1):35\u201341","journal-title":"Sleep Breath"},{"issue":"4","key":"2205_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.5664\/jcsm.27538","volume":"5","author":"JR Cooke","year":"2009","unstructured":"Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S (2009) Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer\u2019s disease and obstructive sleep apnea: a preliminary study. J Clin Sleep Med 5(4):305\u2013309","journal-title":"J Clin Sleep Med"},{"issue":"2","key":"2205_CR15","first-page":"139","volume":"115","author":"T Hiraoka","year":"2013","unstructured":"Hiraoka T, Yamada N (2013) Treatment of psychiatric symptoms in schizophrenia spectrum disorders with comorbid sleep apnea syndrome: a case report. Seishin Shinkeigaku Zasshi = Psychiatr Neurol Jpn 115(2):139\u2013146","journal-title":"Seishin Shinkeigaku Zasshi = Psychiatr Neurol Jpn"},{"issue":"3","key":"2205_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2190\/GGN0-Y09A-QV4X-DBA0","volume":"33","author":"S Boufidis","year":"2003","unstructured":"Boufidis S, Kosmidis MH, Bozikas VP, Daskalopoulou-Vlahoyianni E, Pitsavas S, Karavatos A (2003) Treatment outcome of obstructive sleep apnea syndrome in a patient with schizophrenia: case report. Int J Psychiatry Med 33(3):305\u2013310","journal-title":"Int J Psychiatry Med"},{"issue":"5","key":"2205_CR17","doi-asserted-by":"publisher","first-page":"819","DOI":"10.5664\/jcsm.7114","volume":"14","author":"M Kaminska","year":"2018","unstructured":"Kaminska M, Mery VP, Lafontaine AL, Robinson A, Benedetti A, Gros P, Kimoff RJ (2018) Change in cognition and other non-motor symptoms with obstructive sleep apnea treatment in Parkinson disease. J Clin Sleep Med 14(5):819\u2013828","journal-title":"J Clin Sleep Med"},{"key":"2205_CR18","first-page":"286581","volume":"2013","author":"U Kallweit","year":"2013","unstructured":"Kallweit U, Baumann CR, Harzheim M, Hidalgo H, Pohlau D, Bassetti CL et al (2013) Fatigue and sleep-disordered breathing in multiple sclerosis: a clinically relevant association? Mult Scler Int 2013:286581","journal-title":"Mult Scler Int"},{"issue":"1","key":"2205_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1080\/21646821.2018.1428462","volume":"58","author":"N Haddock","year":"2018","unstructured":"Haddock N, Wells ME (2018) The association between treated and untreated obstructive sleep apnea and depression. Neurodiagn J 58(1):30\u201339","journal-title":"Neurodiagn J"},{"key":"2205_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.smrv.2015.07.002","volume":"28","author":"MA Gupta","year":"2016","unstructured":"Gupta MA, Simpson FC, Lyons DC (2016) The effect of treating obstructive sleep apnea with positive airway pressure on depression and other subjective symptoms: a systematic review and meta-analysis. Sleep Med Rev 28:55\u201368","journal-title":"Sleep Med Rev"},{"issue":"3","key":"2205_CR21","first-page":"205","volume":"19","author":"F Rezaeitalab","year":"2014","unstructured":"Rezaeitalab F, Moharrari F, Saberi S, Asadpour H, Rezaeetalab F (2014) The correlation of anxiety and depression with obstructive sleep apnea syndrome. J Res Med Sci 19(3):205\u2013210","journal-title":"J Res Med Sci"},{"key":"2205_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/5584_2016_61","volume":"944","author":"J Kostrzewa-Janicka","year":"2017","unstructured":"Kostrzewa-Janicka J, Sliwinski P, Wojda M, Rolski D, Mierzwinska-Nastalska E (2017) Mandibular advancement appliance for obstructive sleep apnea treatment. Adv Exp Med Biol 944:63\u201371","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"2205_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/0394632015590949","volume":"29","author":"S Cantore","year":"2016","unstructured":"Cantore S, Ballini A, Farronato D, Malcangi G, Dipalma G, Assandri F, Garagiola U, Inchingolo F, de Vito D, Cirulli N (2016) Evaluation of an oral appliance in patients with mild to moderate obstructive sleep apnea syndrome intolerant to continuous positive airway pressure use: preliminary results. Int J Immunopathol Pharmacol 29(2):267\u2013273","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"2205_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1087-0792(97)90004-6","volume":"1","author":"P Collard","year":"1997","unstructured":"Collard P, Pieters T, Aubert G, Delguste P, Rodenstein DO (1997) Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev 1(1):33\u201344","journal-title":"Sleep Med Rev"},{"issue":"6","key":"2205_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.rmed.2012.10.008","volume":"107","author":"D Ghosh","year":"2013","unstructured":"Ghosh D, Allgar V, Elliott MW (2013) Identifying poor compliance with CPAP in obstructive sleep apnoea: a simple prediction equation using data after a two week trial. Respir Med 107(6):936\u2013942","journal-title":"Respir Med"},{"issue":"6 Suppl","key":"2205_CR26","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1093\/sleep\/15.suppl_6.S42","volume":"15","author":"J Krieger","year":"1992","unstructured":"Krieger J (1992) Long-term compliance with nasal continuous positive airway pressure (CPAP) in obstructive sleep apnea patients and nonapneic snorers. Sleep. 15(6 Suppl):S42\u2013S46","journal-title":"Sleep."},{"key":"2205_CR27","volume":"9","author":"P Samson","year":"2012","unstructured":"Samson P, Casey KR, Knepler J, Panos RJ (2012) Clinical characteristics, comorbidities, and response to treatment of veterans with obstructive sleep apnea, Cincinnati Veterans Affairs Medical Center, 2005-2007. Prev Chronic Dis 9:E46","journal-title":"Prev Chronic Dis"},{"issue":"6","key":"2205_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.sleep.2012.01.004","volume":"13","author":"NT Vozoris","year":"2012","unstructured":"Vozoris NT (2012) Sleep apnea-plus: prevalence, risk factors, and association with cardiovascular diseases using United States population-level data. Sleep Med 13(6):637\u2013644","journal-title":"Sleep Med"},{"key":"2205_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jad.2015.07.006","volume":"185","author":"AR Brunoni","year":"2015","unstructured":"Brunoni AR, Machado-Vieira R, Sampaio-Junior B, Vieira EL, Valiengo L, Bensenor IM et al (2015) Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: results from the SELECT-TDCS trial. J Affect Disord 185:209\u2013213","journal-title":"J Affect Disord"},{"issue":"4","key":"2205_CR30","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","volume":"13","author":"WW Chen","year":"2016","unstructured":"Chen WW, Zhang X, Huang WJ (2016) Role of neuroinflammation in neurodegenerative diseases (review). Mol Med Rep 13(4):3391\u20133396","journal-title":"Mol Med Rep"},{"key":"2205_CR31","doi-asserted-by":"publisher","first-page":"756357","DOI":"10.1100\/2012\/756357","volume":"2012","author":"JM Rubio-Perez","year":"2012","unstructured":"Rubio-Perez JM, Morillas-Ruiz JM (2012) A review: inflammatory process in Alzheimer\u2019s disease, role of cytokines. ScientificWorldJournal. 2012:756357","journal-title":"ScientificWorldJournal."},{"key":"2205_CR32","doi-asserted-by":"publisher","first-page":"2985051","DOI":"10.1155\/2017\/2985051","volume":"2017","author":"M Tortarolo","year":"2017","unstructured":"Tortarolo M, Lo Coco D, Veglianese P, Vallarola A, Giordana MT, Marcon G et al (2017) Amyotrophic lateral sclerosis, a multisystem pathology: insights into the role of TNFalpha. Mediat Inflamm 2017:2985051","journal-title":"Mediat Inflamm"},{"issue":"1","key":"2205_CR33","doi-asserted-by":"publisher","first-page":"9094","DOI":"10.1038\/s41598-017-09097-1","volume":"7","author":"Y Hu","year":"2017","unstructured":"Hu Y, Cao C, Qin XY, Yu Y, Yuan J, Zhao Y, Cheng Y (2017) Increased peripheral blood inflammatory cytokine levels in amyotrophic lateral sclerosis: a meta-analysis study. Sci Rep 7(1):9094","journal-title":"Sci Rep"},{"key":"2205_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2174\/1871527318666190516083008","volume":"18","author":"M Sedighian","year":"2019","unstructured":"Sedighian M, Djafarian K, Dabiri S, Abdollahi M, Shab-Bidar S (2019) Effect of omega-3 supplementation on expanded disability status scale and inflammatory cytokines in multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials. CNS Neurol Disord Drug Targets 18:523\u2013529","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2205_CR35","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.3389\/fimmu.2018.02122","volume":"9","author":"X Chen","year":"2018","unstructured":"Chen X, Hu Y, Cao Z, Liu Q, Cheng Y (2018) Cerebrospinal fluid inflammatory cytokine aberrations in Alzheimer\u2019s disease, Parkinson\u2019s disease and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Front Immunol 9:2122","journal-title":"Front Immunol"},{"key":"2205_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/978-1-4419-6612-4_56","volume":"691","author":"MK McCoy","year":"2011","unstructured":"McCoy MK, Ruhn KA, Blesch A, Tansey MG (2011) TNF: a key neuroinflammatory mediator of neurotoxicity and neurodegeneration in models of Parkinson\u2019s disease. Adv Exp Med Biol 691:539\u2013540","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2205_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0753-3322(99)80079-1","volume":"53","author":"H Bessler","year":"1999","unstructured":"Bessler H, Djaldetti R, Salman H, Bergman M, Djaldetti M (1999) IL-1 beta, IL-2, IL-6 and TNF-alpha production by peripheral blood mononuclear cells from patients with Parkinson\u2019s disease. Biomed Pharmacother 53(3):141\u2013145","journal-title":"Biomed Pharmacother"},{"key":"2205_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2015.06.008","volume":"64","author":"YK Kim","year":"2016","unstructured":"Kim YK, Na KS, Myint AM, Leonard BE (2016) The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 64:277\u2013284","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"5","key":"2205_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanct\u00f4t KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446\u2013457","journal-title":"Biol Psychiatry"},{"issue":"12","key":"2205_CR40","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21(12):1696\u20131709","journal-title":"Mol Psychiatry"},{"issue":"7","key":"2205_CR41","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70(7):663\u2013671","journal-title":"Biol Psychiatry"},{"issue":"4","key":"2205_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","volume":"7","author":"ME Lull","year":"2010","unstructured":"Lull ME, Block ML (2010) Microglial activation and chronic neurodegeneration. Neurotherapeutics. 7(4):354\u2013365","journal-title":"Neurotherapeutics."},{"issue":"4","key":"2205_CR43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/jnr.10508","volume":"71","author":"C Eskes","year":"2003","unstructured":"Eskes C, Juillerat-Jeanneret L, Leuba G, Honegger P, Monnet-Tschudi F (2003) Involvement of microglia-neuron interactions in the tumor necrosis factor-alpha release, microglial activation, and neurodegeneration induced by trimethyltin. J Neurosci Res 71(4):583\u2013590","journal-title":"J Neurosci Res"},{"issue":"4","key":"2205_CR44","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1073\/pnas.94.4.1500","volume":"94","author":"CJ Heyser","year":"1997","unstructured":"Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH (1997) Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A 94(4):1500\u20131505","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2205_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2018.04.023","volume":"1692","author":"J Matsumoto","year":"2018","unstructured":"Matsumoto J, Dohgu S, Takata F, Machida T, Bolukbasi Hatip FF, Hatip-Al-Khatib I et al (2018) TNF-alpha-sensitive brain pericytes activate microglia by releasing IL-6 through cooperation between IkappaB-NFkappaB and JAK-STAT3 pathways. Brain Res 1692:34\u201344","journal-title":"Brain Res"},{"key":"2205_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.mehy.2017.12.004","volume":"110","author":"M Vakil","year":"2018","unstructured":"Vakil M, Park S, Broder A (2018) The complex associations between obstructive sleep apnea and auto-immune disorders: a review. Med Hypotheses 110:138\u2013143","journal-title":"Med Hypotheses"},{"key":"2205_CR47","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3389\/fimmu.2019.02321","volume":"10","author":"A Lewis","year":"2019","unstructured":"Lewis A, Elks PM (2019) Hypoxia induces macrophage tnfa expression via cyclooxygenase and prostaglandin E2 in vivo. Front Immunol 10:2321","journal-title":"Front Immunol"},{"issue":"12","key":"2205_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081584","volume":"8","author":"SM Smith","year":"2013","unstructured":"Smith SM, Friedle SA, Watters JJ (2013) Chronic intermittent hypoxia exerts CNS region-specific effects on rat microglial inflammatory and TLR4 gene expression. PLoS One 8(12):e81584","journal-title":"PLoS One"},{"issue":"3","key":"2205_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00418-008-0437-4","volume":"130","author":"SY Lam","year":"2008","unstructured":"Lam SY, Tipoe GL, Liong EC, Fung ML (2008) Chronic hypoxia upregulates the expression and function of proinflammatory cytokines in the rat carotid body. Histochem Cell Biol 130(3):549\u2013559","journal-title":"Histochem Cell Biol"},{"key":"2205_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12974-014-0215-2","volume":"11","author":"LW Wang","year":"2014","unstructured":"Wang LW, Chang YC, Chen SJ, Tseng CH, Tu YF, Liao NS, Huang CC, Ho CJ (2014) TNFR1-JNK signaling is the shared pathway of neuroinflammation and neurovascular damage after LPS-sensitized hypoxic-ischemic injury in the immature brain. J Neuroinflammation 11:215","journal-title":"J Neuroinflammation"},{"key":"2205_CR51","doi-asserted-by":"crossref","unstructured":"Kheirandish-Gozal L, Gozal D (2019) Obstructive sleep apnea and inflammation: proof of concept based on two illustrative cytokines. Int J Mol Sci 20(3)","DOI":"10.3390\/ijms20030459"},{"issue":"2","key":"2205_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5604\/00306657.1147029","volume":"69","author":"S De Santis","year":"2015","unstructured":"De Santis S, Cambi J, Tatti P, Bellussi L, Passali D (2015) Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in obstructive sleep apnea syndrome (OSAS) patients. Pol Otolaryngol 69(2):1\u20138","journal-title":"Pol Otolaryngol"},{"issue":"8","key":"2205_CR53","first-page":"1357","volume":"31","author":"ZM Shi","year":"2011","unstructured":"Shi ZM, Li TP, Xian LW, Li ZG (2011) Role of inflammation factors in impaired glucose tolerance and sleep apnea\/hypopnea syndrome in pregnant women. Nan Fang Yi Ke Da Xue Xue Bao 31(8):1357\u20131359","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"4","key":"2205_CR54","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s10753-012-9464-3","volume":"35","author":"X Qian","year":"2012","unstructured":"Qian X, Yin T, Li T, Kang C, Guo R, Sun B, Liu C (2012) High levels of inflammation and insulin resistance in obstructive sleep apnea patients with hypertension. Inflammation. 35(4):1507\u20131511","journal-title":"Inflammation."},{"issue":"4","key":"2205_CR55","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1183\/13993003.00234-2016","volume":"48","author":"E Vicente","year":"2016","unstructured":"Vicente E, Marin JM, Carrizo SJ, Osuna CS, Gonzalez R, Marin-Oto M et al (2016) Upper airway and systemic inflammation in obstructive sleep apnoea. Eur Respir J 48(4):1108\u20131117","journal-title":"Eur Respir J"},{"issue":"9","key":"2205_CR56","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archoto.2010.142","volume":"136","author":"J Kim","year":"2010","unstructured":"Kim J, Lee CH, Park CS, Kim BG, Kim SW, Cho JH (2010) Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg 136(9):896\u2013899","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"6","key":"2205_CR57","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1007\/s10753-013-9673-4","volume":"36","author":"OK Kurt","year":"2013","unstructured":"Kurt OK, Tosun M, Talay F (2013) Serum cardiotrophin-1 and IL-6 levels in patients with obstructive sleep apnea syndrome. Inflammation. 36(6):1344\u20131347","journal-title":"Inflammation."},{"issue":"5","key":"2205_CR58","doi-asserted-by":"publisher","first-page":"E851","DOI":"10.1152\/ajpendo.00249.2016","volume":"311","author":"J Gaines","year":"2016","unstructured":"Gaines J, Vgontzas AN, Fernandez-Mendoza J, Calhoun SL, He F, Liao D, Sawyer MD, Bixler EO (2016) Inflammation mediates the association between visceral adiposity and obstructive sleep apnea in adolescents. Am J Physiol Endocrinol Metab 311(5):E851\u2013E8E8","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"2205_CR59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11325-011-0512-2","volume":"16","author":"A Hegglin","year":"2012","unstructured":"Hegglin A, Schoch OD, Korte W, Hahn K, Hurny C, Munzer T (2012) Eight months of continuous positive airway pressure (CPAP) decrease tumor necrosis factor alpha (TNFA) in men with obstructive sleep apnea syndrome. Sleep Breath 16(2):405\u2013412","journal-title":"Sleep Breath"},{"issue":"6","key":"2205_CR60","first-page":"6176","volume":"14","author":"YQ Jiang","year":"2017","unstructured":"Jiang YQ, Xue JS, Xu J, Zhou ZX, Ji YL (2017) Efficacy of continuous positive airway pressure treatment in treating obstructive sleep apnea hypopnea syndrome associated with carotid arteriosclerosis. Exp Ther Med 14(6):6176\u20136182","journal-title":"Exp Ther Med"},{"issue":"5","key":"2205_CR61","doi-asserted-by":"publisher","first-page":"6334","DOI":"10.3892\/mmr.2017.7399","volume":"16","author":"F Jin","year":"2017","unstructured":"Jin F, Liu J, Zhang X, Cai W, Zhang Y, Zhang W, Yang J, Lu G, Zhang X (2017) Effect of continuous positive airway pressure therapy on inflammatory cytokines and atherosclerosis in patients with obstructive sleep apnea syndrome. Mol Med Rep 16(5):6334\u20136339","journal-title":"Mol Med Rep"},{"issue":"2","key":"2205_CR62","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00408-013-9550-9","volume":"192","author":"M Yoshikawa","year":"2014","unstructured":"Yoshikawa M, Yamauchi M, Fujita Y, Koyama N, Fukuoka A, Tamaki S, Yamamoto Y, Tomoda K, Kimura H (2014) The impact of obstructive sleep apnea and nasal CPAP on circulating adiponectin levels. Lung. 192(2):289\u2013295","journal-title":"Lung."},{"issue":"4","key":"2205_CR63","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/clc.21010","volume":"35","author":"J Oyama","year":"2012","unstructured":"Oyama J, Yamamoto H, Maeda T, Ito A, Node K, Makino N (2012) Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol 35(4):231\u2013236","journal-title":"Clin Cardiol"},{"issue":"4","key":"2205_CR64","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/sleep\/32.4.537","volume":"32","author":"P Steiropoulos","year":"2009","unstructured":"Steiropoulos P, Kotsianidis I, Nena E, Tsara V, Gounari E, Hatzizisi O, Kyriazis G, Christaki P, Froudarakis M, Bouros D (2009) Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome. Sleep. 32(4):537\u2013543","journal-title":"Sleep."},{"issue":"4","key":"2205_CR65","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1378\/chest.08-0556","volume":"134","author":"Z Dorkova","year":"2008","unstructured":"Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R (2008) Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest. 134(4):686\u2013692","journal-title":"Chest."},{"issue":"3","key":"2205_CR66","first-page":"1766","volume":"17","author":"H Ming","year":"2019","unstructured":"Ming H, Tian A, Liu B, Hu Y, Liu C, Chen R et al (2019) Inflammatory cytokines tumor necrosis factor-alpha, interleukin-8 and sleep monitoring in patients with obstructive sleep apnea syndrome. Exp Ther Med 17(3):1766\u20131770","journal-title":"Exp Ther Med"},{"key":"2205_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/518920","volume":"2014","author":"F Unuvar Dogan","year":"2014","unstructured":"Unuvar Dogan F, Yosunkaya S, Kuzu Okur H, Can U (2014) Relationships between obstructive sleep apnea syndrome, continuous positive airway pressure treatment, and inflammatory cytokines. Sleep Disord 2014:1\u20136","journal-title":"Sleep Disord"},{"issue":"2","key":"2205_CR68","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11325-012-0761-8","volume":"18","author":"H Karamanli","year":"2014","unstructured":"Karamanli H, Ozol D, Ugur KS, Yildirim Z, Armutcu F, Bozkurt B et al (2014) Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath 18(2):251\u2013256","journal-title":"Sleep Breath"},{"issue":"5\u20136","key":"2205_CR69","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s12026-016-8869-8","volume":"64","author":"M Can","year":"2016","unstructured":"Can M, Uygur F, Tanriverdi H, Acikgoz B, Alper B, Guven B (2016) Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea. Immunol Res 64(5\u20136):1179\u20131184","journal-title":"Immunol Res"},{"issue":"6","key":"2205_CR70","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000631","volume":"6","author":"M Wosiski-Kuhn","year":"2019","unstructured":"Wosiski-Kuhn M, Robinson M, Strupe J, Arounleut P, Martin M, Caress J, Cartwright M, Bowser R, Cudkowicz M, Langefeld C, Hawkins GA, Milligan C (2019) IL6 receptor(358)Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm 6(6):e631","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"2205_CR71","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/glia.22948","volume":"64","author":"V Senecal","year":"2016","unstructured":"Senecal V, Deblois G, Beauseigle D, Schneider R, Brandenburg J, Newcombe J et al (2016) Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: modulation of local immune responses. Glia. 64(4):553\u2013569","journal-title":"Glia."},{"issue":"3","key":"2205_CR72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.celrep.2019.09.017","volume":"29","author":"S Lobentanzer","year":"2019","unstructured":"Lobentanzer S, Hanin G, Klein J, Soreq H (2019) Integrative transcriptomics reveals sexually dimorphic control of the cholinergic\/neurokine Interface in schizophrenia and bipolar disorder. Cell Rep 29(3):764\u2013777 e5","journal-title":"Cell Rep"},{"issue":"19","key":"2205_CR73","doi-asserted-by":"publisher","first-page":"19936","DOI":"10.1074\/jbc.M309304200","volume":"279","author":"K Sriram","year":"2004","unstructured":"Sriram K, Benkovic SA, Hebert MA, Miller DB, O\u2019Callaghan JP (2004) Induction of gp130-related cytokines and activation of JAK2\/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? J Biol Chem 279(19):19936\u201319947","journal-title":"J Biol Chem"},{"issue":"2","key":"2205_CR74","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0306-4522(03)00593-1","volume":"122","author":"DR Rosell","year":"2003","unstructured":"Rosell DR, Nacher J, Akama KT, McEwen BS (2003) Spatiotemporal distribution of gp130 cytokines and their receptors after status epilepticus: comparison with neuronal degeneration and microglial activation. Neuroscience. 122(2):329\u2013348","journal-title":"Neuroscience."},{"key":"2205_CR75","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pnpbp.2012.10.022","volume":"48","author":"KS Na","year":"2014","unstructured":"Na KS, Jung HY, Kim YK (2014) The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry 48:277\u2013286","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"4","key":"2205_CR76","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1046\/j.1471-4159.2002.01184.x","volume":"83","author":"E Pinteaux","year":"2002","unstructured":"Pinteaux E, Parker LC, Rothwell NJ, Luheshi GN (2002) Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem 83(4):754\u2013763","journal-title":"J Neurochem"},{"issue":"3","key":"2205_CR77","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1471-4159.2005.03566.x","volume":"96","author":"K Sriram","year":"2006","unstructured":"Sriram K, Miller DB, O\u2019Callaghan JP (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 96(3):706\u2013718","journal-title":"J Neurochem"},{"key":"2205_CR78","doi-asserted-by":"publisher","first-page":"1396398","DOI":"10.1155\/2017\/1396398","volume":"2017","author":"ML Morieri","year":"2017","unstructured":"Morieri ML, Passaro A, Zuliani G (2017) Interleukin-6 \u201ctrans-signaling\u201d and ischemic vascular disease: the important role of soluble gp130. Mediat Inflamm 2017:1396398","journal-title":"Mediat Inflamm"},{"issue":"9","key":"2205_CR79","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J (2012) Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci 8(9):1254\u20131266","journal-title":"Int J Biol Sci"},{"issue":"6 Pt A","key":"2205_CR80","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.bbamcr.2016.03.018","volume":"1863","author":"M Rothaug","year":"2016","unstructured":"Rothaug M, Becker-Pauly C, Rose-John S (2016) The role of interleukin-6 signaling in nervous tissue. Biochim Biophys Acta 1863(6 Pt A):1218\u20131227","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2205_CR81","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000204230","volume":"16","author":"R Reuss","year":"2009","unstructured":"Reuss R, Pohle S, Retzlaff K, Hemberger J, Oschmann P (2009) Interferon beta-1a induces tumor necrosis factor receptor 1 but decreases tumor necrosis factor receptor 2 leukocyte mRNA levels in relapsing-remitting multiple sclerosis. Neuroimmunomodulation. 16(3):171\u2013176","journal-title":"Neuroimmunomodulation."},{"issue":"2","key":"2205_CR82","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1084\/jem.170.2.607","volume":"170","author":"FM Hofman","year":"1989","unstructured":"Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170(2):607\u2013612","journal-title":"J Exp Med"},{"issue":"14","key":"2205_CR83","first-page":"3080","volume":"25","author":"L Brambilla","year":"2016","unstructured":"Brambilla L, Guidotti G, Martorana F, Iyer AM, Aronica E, Valori CF, Rossi D (2016) Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis. Hum Mol Genet 25(14):3080\u20133095","journal-title":"Hum Mol Genet"},{"issue":"11","key":"2205_CR84","doi-asserted-by":"publisher","first-page":"8442","DOI":"10.1167\/iovs.11-8152","volume":"52","author":"X Yang","year":"2011","unstructured":"Yang X, Luo C, Cai J, Powell DW, Yu D, Kuehn MH, Tezel G (2011) Neurodegenerative and inflammatory pathway components linked to TNF-alpha\/TNFR1 signaling in the glaucomatous human retina. Invest Ophthalmol Vis Sci 52(11):8442\u20138454","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1\u20132","key":"2205_CR85","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jneuroim.2009.08.001","volume":"216","author":"P Scalzo","year":"2009","unstructured":"Scalzo P, Kummer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson\u2019s disease. J Neuroimmunol 216(1\u20132):122\u2013125","journal-title":"J Neuroimmunol"},{"issue":"1","key":"2205_CR86","first-page":"65","volume":"64","author":"K Bobinska","year":"2017","unstructured":"Bobinska K, Galecka E, Szemraj J, Galecki P, Talarowska M (2017) Is there a link between TNF gene expression and cognitive deficits in depression? Acta Biochim Pol 64(1):65\u201373","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"2205_CR87","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/hup.2450","volume":"30","author":"AL Teixeira","year":"2015","unstructured":"Teixeira AL, de Sousa RT, Zanetti MV, Brunoni AR, Busatto GF, Zarate CA Jr et al (2015) Increased plasma levels of soluble TNF receptors 1 and 2 in bipolar depression and impact of lithium treatment. Hum Psychopharmacol 30(1):52\u201356","journal-title":"Hum Psychopharmacol"},{"issue":"6","key":"2205_CR88","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.eurpsy.2008.03.013","volume":"23","author":"H Himmerich","year":"2008","unstructured":"Himmerich H, Fulda S, Linseisen J, Seiler H, Wolfram G, Himmerich S, Gedrich K, Kloiber S, Lucae S, Ising M, Uhr M, Holsboer F, Pollm\u00e4cher T (2008) Depression, comorbidities and the TNF-alpha system. Eur Psychiatry. 23(6):421\u2013429","journal-title":"Eur Psychiatry."},{"key":"2205_CR89","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2019.00049","volume":"13","author":"N Orti-Casan","year":"2019","unstructured":"Orti-Casan N, Wu Y, Naude PJW, De Deyn PP, Zuhorn IS, Eisel ULM (2019) Targeting TNFR2 as a novel therapeutic strategy for Alzheimer\u2019s disease. Front Neurosci 13:49","journal-title":"Front Neurosci"},{"issue":"4","key":"2205_CR90","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3233\/JAD-2010-100921","volume":"22","author":"BS Diniz","year":"2010","unstructured":"Diniz BS, Teixeira AL, Ojopi EB, Talib LL, Mendonca VA, Gattaz WF et al (2010) Higher serum sTNFR1 level predicts conversion from mild cognitive impairment to Alzheimer\u2019s disease. J Alzheimers Dis 22(4):1305\u20131311","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"2205_CR91","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3233\/JAD-2010-1253","volume":"19","author":"X Cheng","year":"2010","unstructured":"Cheng X, Yang L, He P, Li R, Shen Y (2010) Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer\u2019s disease and non-demented patients. J Alzheimers Dis 19(2):621\u2013630","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"2205_CR92","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.exger.2006.12.001","volume":"42","author":"D Culpan","year":"2007","unstructured":"Culpan D, Cornish A, Love S, Kehoe PG, Wilcock GK (2007) Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer\u2019s disease. Exp Gerontol 42(6):538\u2013544","journal-title":"Exp Gerontol"},{"issue":"4","key":"2205_CR93","first-page":"881","volume":"43","author":"EZ Hoseth","year":"2017","unstructured":"Hoseth EZ, Ueland T, Dieset I, Birnbaum R, Shin JH, Kleinman JE, Hyde TM, M\u00f8rch RH, Hope S, Lekva T, Abraityte AJ, Michelsen AE, Melle I, Westlye LT, Ueland T, Djurovic S, Aukrust P, Weinberger DR, Andreassen OA (2017) A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue. Schizophr Bull 43(4):881\u2013890","journal-title":"Schizophr Bull"},{"issue":"5","key":"2205_CR94","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3109\/08039488.2015.1122079","volume":"70","author":"L Turhan","year":"2016","unstructured":"Turhan L, Batmaz S, Kocbiyik S, Soygur AH (2016) The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia. Nord J Psychiatry 70(5):342\u2013350","journal-title":"Nord J Psychiatry"},{"issue":"4","key":"2205_CR95","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jpsychires.2012.12.010","volume":"47","author":"C Noto","year":"2013","unstructured":"Noto C, Gadelha A, Belangero SI, Spindola LM, Rocha NP, de Miranda AS, Teixeira AL, Cardoso Smith MA, de Jesus Mari J, Bressan RA, Brietzke E (2013) Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia. J Psychiatr Res 47(4):467\u2013471","journal-title":"J Psychiatr Res"},{"issue":"2","key":"2205_CR96","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1159\/000148197","volume":"15","author":"FM Coelho","year":"2008","unstructured":"Coelho FM, Reis HJ, Nicolato R, Romano-Silva MA, Teixeira MM, Bauer ME, Teixeira AL (2008) Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation. 15(2):140\u2013144","journal-title":"Neuroimmunomodulation."},{"key":"2205_CR97","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3390\/antib4040369","volume":"4","author":"Y Dong","year":"2015","unstructured":"Dong Y, Dekens DW, De Deyn PP, Naud\u00e9 PJW, Eisel ULM (2015) Targeting of tumor necrosis factor alpha receptors as a therapeutic strategy for neurodegenerative disorders. Antibodies 4:369\u2013408","journal-title":"Antibodies"},{"issue":"1","key":"2205_CR98","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1096\/fj.04-2073fje","volume":"19","author":"GH Waetzig","year":"2005","unstructured":"Waetzig GH, Rosenstiel P, Arlt A, Till A, Brautigam K, Schafer H et al (2005) Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1. FASEB J 19(1):91\u201393","journal-title":"FASEB J"},{"issue":"3","key":"2205_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122073","volume":"10","author":"N Neirynck","year":"2015","unstructured":"Neirynck N, Glorieux G, Schepers E, Verbeke F, Vanholder R (2015) Soluble tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic kidney disease: a prospective cohort study. PLoS One 10(3):e0122073","journal-title":"PLoS One"},{"key":"2205_CR100","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/antib4010048","volume":"4","author":"R Fischer","year":"2015","unstructured":"Fischer R, Kontermann R, Maier O (2015) Targeting sTNF\/TNFR1 signaling as a new therapeutic strategy. Antibodies. 4:48\u201370","journal-title":"Antibodies."},{"issue":"4","key":"2205_CR101","first-page":"169","volume":"3","author":"T Watanabe","year":"2000","unstructured":"Watanabe T, Kumano-Go T, Suganuma N, Shigedo Y, Motonishi M, Honda H, Kyotani K, Uruha S, Terashima K, Teshima Y, Takeda M, Sugita Y (2000) The relationship between esophageal pressure and apnea hypopnea index in obstructive sleep apnea-hypopnea syndrome. Sleep Res Online 3(4):169\u2013172","journal-title":"Sleep Res Online"},{"issue":"3","key":"2205_CR102","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1046\/j.1440-1819.2000.00704.x","volume":"54","author":"T Watanabe","year":"2000","unstructured":"Watanabe T, Mikami A, Shigedo Y, Motonishi M, Honda H, Kyotani K, Uruha S, Terashima K, Teshima Y, Sugita Y, Takeda M (2000) Esophageal pressure and apnea hypopnea index in sleep-disordered breathing. Psychiatry Clin Neurosci 54(3):338\u2013339","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"2205_CR103","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/sleep\/18.5.368","volume":"18","author":"LJ Epstein","year":"1995","unstructured":"Epstein LJ, Strollo PJ Jr, Donegan RB, Delmar J, Hendrix C, Westbrook PR (1995) Obstructive sleep apnea in patients with human immunodeficiency virus (HIV) disease. Sleep. 18(5):368\u2013376","journal-title":"Sleep."},{"issue":"6","key":"2205_CR104","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0016-5107(89)72904-7","volume":"35","author":"JS Barkin","year":"1989","unstructured":"Barkin JS, Krieger B, Blinder M, Bosch-Blinder L, Goldberg RI, Phillips RS (1989) Oxygen desaturation and changes in breathing pattern in patients undergoing colonoscopy and gastroscopy. Gastrointest Endosc 35(6):526\u2013530","journal-title":"Gastrointest Endosc"},{"issue":"21","key":"2205_CR105","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1161\/01.CIR.0000018948.95175.03","volume":"105","author":"AS Shamsuzzaman","year":"2002","unstructured":"Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 105(21):2462\u20132464","journal-title":"Circulation."},{"issue":"2","key":"2205_CR106","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4103\/2229-3485.71856","volume":"1","author":"TV Sakpal","year":"2010","unstructured":"Sakpal TV (2010) Sample size estimation in clinical trial. Perspect Clin Res 1(2):67\u201369","journal-title":"Perspect Clin Res"},{"issue":"10","key":"2205_CR107","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1080\/02664763.2012.702265","volume":"39","author":"J-H Guo","year":"2012","unstructured":"Guo J-H (2012) Optimal sample size planning for the Wilcoxon\u2013Mann\u2013Whitney and van Elteren tests under cost constraints. J Appl Stat 39(10):2153\u20132164","journal-title":"J Appl Stat"},{"issue":"3","key":"2205_CR108","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/sim.7983","volume":"38","author":"M Happ","year":"2019","unstructured":"Happ M, Bathke AC, Brunner E (2019) Optimal sample size planning for the Wilcoxon-Mann-Whitney test. Stat Med 38(3):363\u2013375","journal-title":"Stat Med"},{"key":"2205_CR109","unstructured":"Gray G (2018) Adaptive designs for medical device clinical studies: guidance for Industry and Food and Drug Administration Staff.1-49"},{"key":"2205_CR110","first-page":"2579","volume":"9","author":"L van der Maaten","year":"2008","unstructured":"van der Maaten L, Hinton G (2008) Visualizing data using t-SNE. JMLR 9:2579\u20132605","journal-title":"JMLR"},{"key":"2205_CR111","unstructured":"Krijthe J. Rtsne: T-Distributed Stochastic Neighbor Embedding Using a Barnes-Hut Implementation. Available from: https:\/\/github.com\/jkrijthe\/Rtsne"},{"issue":"2","key":"2205_CR112","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/ijms17020206","volume":"17","author":"I Lopez Gonzalez","year":"2016","unstructured":"Lopez Gonzalez I, Garcia-Esparcia P, Llorens F, Ferrer I (2016) Genetic and Transcriptomic profiles of inflammation in neurodegenerative diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies. Int J Mol Sci 17(2):206","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2205_CR113","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00406-004-0558-2","volume":"255","author":"H Hampel","year":"2005","unstructured":"Hampel H, Haslinger A, Scheloske M, Padberg F, Fischer P, Unger J, Teipel SJ, Neumann M, Rosenberg C, Oshida R, Hulette C, Pongratz D, Ewers M, Kretzschmar HA, M\u00f6ller HJ (2005) Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer\u2019s disease brain. Eur Arch Psychiatry Clin Neurosci 255(4):269\u2013278","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"2205_CR114","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0304-3940(97)00886-0","volume":"239","author":"P Marz","year":"1997","unstructured":"Marz P, Heese K, Hock C, Golombowski S, Muller-Spahn F, Rose-John S et al (1997) Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer\u2019s disease patients. Neurosci Lett 239(1):29\u201332","journal-title":"Neurosci Lett"},{"issue":"1","key":"2205_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01124","volume":"5","author":"A Sundaresh","year":"2019","unstructured":"Sundaresh A, Oliveira J, Chinnadurai RK, Rajkumar RP, Hani L, Krishnamoorthy R, Leboyer M, Negi VS, Tamouza R (2019) IL6\/IL6R genetic diversity and plasma IL6 levels in bipolar disorder: an indo-French study. Heliyon. 5(1):e01124","journal-title":"Heliyon."},{"issue":"1","key":"2205_CR116","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/tpj.2016.88","volume":"18","author":"M Maldonado-Montoro","year":"2018","unstructured":"Maldonado-Montoro M, Canadas-Garre M, Gonzalez-Utrilla A, Angel C-HM (2018) Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis. Pharmacogenomics J 18(1):167\u2013172","journal-title":"Pharmacogenomics J"},{"key":"2205_CR117","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbi.2017.11.020","volume":"69","author":"GM Khandaker","year":"2018","unstructured":"Khandaker GM, Zammit S, Burgess S, Lewis G, Jones PB (2018) Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort. Brain Behav Immun 69:264\u2013272","journal-title":"Brain Behav Immun"},{"key":"2205_CR118","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eurpsy.2019.05.003","volume":"60","author":"M Draganov","year":"2019","unstructured":"Draganov M, Arranz MJ, Salazar J, de Diego-Adelino J, Gallego-Fabrega C, Jubero M et al (2019) Association study of polymorphisms within inflammatory genes and methylation status in treatment response in major depression. Eur Psychiatry 60:7\u201313","journal-title":"Eur Psychiatry"},{"issue":"5","key":"2205_CR119","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1172\/JCI96462","volume":"128","author":"Y Tamura","year":"2018","unstructured":"Tamura Y, Phan C, Tu L, Le Hiress M, Thuillet R, Jutant EM et al (2018) Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension. J Clin Invest 128(5):1956\u20131970","journal-title":"J Clin Invest"},{"issue":"3","key":"2205_CR120","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00418-011-0900-5","volume":"137","author":"SY Lam","year":"2012","unstructured":"Lam SY, Liu Y, Ng KM, Lau CF, Liong EC, Tipoe GL, Fung ML (2012) Chronic intermittent hypoxia induces local inflammation of the rat carotid body via functional upregulation of proinflammatory cytokine pathways. Histochem Cell Biol 137(3):303\u2013317","journal-title":"Histochem Cell Biol"},{"key":"2205_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2018.11.023","volume":"114","author":"N Prenissl","year":"2019","unstructured":"Prenissl N, Lokau J, Rose-John S, Haybaeck J, Garbers C (2019) Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage. Cytokine. 114:1\u20135","journal-title":"Cytokine."},{"issue":"10","key":"2205_CR122","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"2205_CR123","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025333","volume":"8","author":"GM Khandaker","year":"2018","unstructured":"Khandaker GM, Oltean BP, Kaser M, Dibben CRM, Ramana R, Jadon DR, Dantzer R, Coles AJ, Lewis G, Jones PB (2018) Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation. BMJ Open 8(9):e025333","journal-title":"BMJ Open"},{"issue":"6","key":"2205_CR124","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/npp.2017.258","volume":"43","author":"RR Girgis","year":"2018","unstructured":"Girgis RR, Ciarleglio A, Choo T, Haynes G, Bathon JM, Cremers S, Kantrowitz JT, Lieberman JA, Brown AS (2018) A randomized, double-blind, placebo-controlled clinical trial of Tocilizumab, an Interleukin-6 receptor antibody, for residual symptoms in schizophrenia. Neuropsychopharmacology. 43(6):1317\u20131323","journal-title":"Neuropsychopharmacology."},{"issue":"2","key":"2205_CR125","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","volume":"32","author":"H Schuett","year":"2012","unstructured":"Schuett H, Oestreich R, Waetzig GH, Annema W, Luchtefeld M, Hillmer A, Bavendiek U, von Felden J, Divchev D, Kempf T, Wollert KC, Seegert D, Rose-John S, Tietge UJF, Schieffer B, Grote K (2012) Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice. Arterioscler Thromb Vasc Biol 32(2):281\u2013290","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2205_CR126","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1517\/14728222.2014.888417","volume":"18","author":"M Maes","year":"2014","unstructured":"Maes M, Anderson G, Kubera M, Berk M (2014) Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opin Ther Targets 18(5):495\u2013512","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"2205_CR127","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-14-2291","volume":"21","author":"JF Rossi","year":"2015","unstructured":"Rossi JF, Lu ZY, Jourdan M, Klein B (2015) Interleukin-6 as a therapeutic target. Clin Cancer Res 21(6):1248\u20131257","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2205_CR128","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1042\/BSR20110089","volume":"32","author":"MD Turner","year":"2012","unstructured":"Turner MD, Chaudhry A, Nedjai B (2012) Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. Biosci Rep 32(2):105\u2013112","journal-title":"Biosci Rep"},{"key":"2205_CR129","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fimmu.2013.00478","volume":"4","author":"DL Faustman","year":"2013","unstructured":"Faustman DL, Davis M (2013) TNF receptor 2 and disease: autoimmunity and regenerative medicine. Front Immunol 4:478","journal-title":"Front Immunol"},{"issue":"1","key":"2205_CR130","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1165\/rcmb.2010-0025OC","volume":"45","author":"L Dyugovskaya","year":"2011","unstructured":"Dyugovskaya L, Polyakov A, Ginsberg D, Lavie P, Lavie L (2011) Molecular pathways of spontaneous and TNF-{alpha}-mediated neutrophil apoptosis under intermittent hypoxia. Am J Respir Cell Mol Biol 45(1):154\u2013162","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"2205_CR131","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3109\/00207454.2014.960521","volume":"125","author":"F Hanikoglu","year":"2015","unstructured":"Hanikoglu F, Huseyinoglu N, Ozben S, Cort A, Ozdem S, Ozben T (2015) Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome. Int J Neurosci 125(9):655\u2013662","journal-title":"Int J Neurosci"},{"key":"2205_CR132","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbi.2014.11.013","volume":"47","author":"J Gaines","year":"2015","unstructured":"Gaines J, Vgontzas AN, Fernandez-Mendoza J, Kritikou I, Basta M, Bixler EO (2015) Gender differences in the association of sleep apnea and inflammation. Brain Behav Immun 47:211\u2013217","journal-title":"Brain Behav Immun"},{"issue":"1","key":"2205_CR133","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1183\/09031936.00126712","volume":"43","author":"I Kritikou","year":"2014","unstructured":"Kritikou I, Basta M, Vgontzas AN, Pejovic S, Liao D, Tsaoussoglou M, Bixler EO, Stefanakis Z, Chrousos GP (2014) Sleep apnoea, sleepiness, inflammation and insulin resistance in middle-aged males and females. Eur Respir J 43(1):145\u2013155","journal-title":"Eur Respir J"},{"issue":"4","key":"2205_CR134","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1183\/09031936.00007008","volume":"32","author":"MA Arias","year":"2008","unstructured":"Arias MA, Garcia-Rio F, Alonso-Fernandez A, Hernanz A, Hidalgo R, Martinez-Mateo V, Bartolome S, Rodriguez-Padial L (2008) CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J 32(4):1009\u20131015","journal-title":"Eur Respir J"},{"issue":"5","key":"2205_CR135","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000336120","volume":"33","author":"AB Kunz","year":"2012","unstructured":"Kunz AB, Kraus J, Young P, Reuss R, Wipfler P, Oschmann P, Blaes F, Dziewas R (2012) Biomarkers of inflammation and endothelial dysfunction in stroke with and without sleep apnea. Cerebrovasc Dis 33(5):453\u2013460","journal-title":"Cerebrovasc Dis"},{"key":"2205_CR136","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","volume":"9","author":"S Yang","year":"2018","unstructured":"Yang S, Wang J, Brand DD, Zheng SG (2018) Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications. Front Immunol 9:784","journal-title":"Front Immunol"},{"issue":"4","key":"2205_CR137","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2174\/156720206778792911","volume":"3","author":"YH Ding","year":"2006","unstructured":"Ding YH, Mrizek M, Lai Q, Wu Y, Reyes R Jr, Li J et al (2006) Exercise preconditioning reduces brain damage and inhibits TNF-alpha receptor expression after hypoxia\/reoxygenation: an in vivo and in vitro study. Curr Neurovasc Res 3(4):263\u2013271","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"2205_CR138","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/1097-0320(20010901)45:1<27::AID-CYTO1141>3.0.CO;2-I","volume":"45","author":"KL Kellar","year":"2001","unstructured":"Kellar KL, Kalwar RR, Dubois KA, Crouse D, Chafin WD, Kane BE (2001) Multiplexed fluorescent bead-based immunoassays for quantitation of human cytokines in serum and culture supernatants. Cytometry. 45(1):27\u201336","journal-title":"Cytometry."},{"key":"2205_CR139","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-4939-0928-5_6","volume":"1172","author":"G Moncunill","year":"2014","unstructured":"Moncunill G, Campo JJ, Dobano C (2014) Quantification of multiple cytokines and chemokines using cytometric bead arrays. Methods Mol Biol 1172:65\u201386","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2205_CR140","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072156","volume":"8","author":"F Richter","year":"2013","unstructured":"Richter F, Liebig T, Guenzi E, Herrmann A, Scheurich P, Pfizenmaier K, Kontermann RE (2013) Antagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivity. PLoS One 8(8):e72156","journal-title":"PLoS One"},{"issue":"43","key":"2205_CR141","doi-asserted-by":"publisher","first-page":"12304","DOI":"10.1073\/pnas.1605195113","volume":"113","author":"Y Dong","year":"2016","unstructured":"Dong Y, Fischer R, Naude PJ, Maier O, Nyakas C, Duffey M et al (2016) Essential protective role of tumor necrosis factor receptor 2 in neurodegeneration. Proc Natl Acad Sci U S A 113(43):12304\u201312309","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2205_CR142","doi-asserted-by":"publisher","first-page":"13628","DOI":"10.1038\/s41598-018-31957-7","volume":"8","author":"SK Williams","year":"2018","unstructured":"Williams SK, Fairless R, Maier O, Liermann PC, Pichi K, Fischer R, Eisel ULM, Kontermann R, Herrmann A, Weksler B, Romero N, Couraud PO, Pfizenmaier K, Diem R (2018) Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis. Sci Rep 8(1):13628","journal-title":"Sci Rep"},{"issue":"6","key":"2205_CR143","first-page":"1139","volume":"16","author":"T Nubel","year":"2005","unstructured":"Nubel T, Schmitt S, Kaina B, Fritz G (2005) Lovastatin stimulates p75 TNF receptor (TNFR2) expression in primary human endothelial cells. Int J Mol Med 16(6):1139\u20131145","journal-title":"Int J Mol Med"},{"issue":"2","key":"2205_CR144","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3233\/JAD-2009-1052","volume":"17","author":"AM Dolga","year":"2009","unstructured":"Dolga AM, Granic I, Nijholt IM, Nyakas C, van der Zee EA, Luiten PG et al (2009) Pretreatment with lovastatin prevents N-methyl-D-aspartate-induced neurodegeneration in the magnocellular nucleus basalis and behavioral dysfunction. J Alzheimers Dis 17(2):327\u2013336","journal-title":"J Alzheimers Dis"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-020-02205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-020-02205-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-020-02205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T19:32:28Z","timestamp":1723750348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-020-02205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2205"],"URL":"https:\/\/doi.org\/10.1007\/s11325-020-02205-y","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Yes.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No consent for publication is needed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}